Terminal
Spotlight
Cashu Research

← Back to Terminal

Stocks
Healthcare
NASDAQ
CMPS

Market Cap: $1.53B

CP

COMPASS Pathways plc

CMPS

NASDAQ (NASDAQ Global Select)USD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Advertisers Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Cashu Research is part of Cashu Technology Pty Ltd, which is an authorised representative (AR # 001318029) of Adviser Solutions Group Pty Ltd (ABN 88 601 875 521) (AFSL 485946) (ASG).

This material is general advice only and is not an offer for the purchase or sale of any financial product or service. The material is not intended to provide you with personal financial or tax advice and does not take into account your personal objectives, financial situation or needs. Although we believe that the material is correct, no warranty of accuracy, reliability or completeness is given, except for liability under statute which cannot be excluded. Please note that past performance may not be indicative of future performance and that no guarantee of performance, the return of capital or a particular rate of return is given by Cashu Technologies Pty Ltd, any of their related body corporates or any other person. To the maximum extent possible, Cashu Technologies Pty Ltd, their related body corporates or any other person do not accept any liability for any statement in this material.

News

Compass Pathways Plc: Advancing Psilocybin Therapy for Mental Health Breakthroughs

Innovative Psilocybin Treatment Advances Mental Health Solutions Compass Pathways Plc, a pioneering biotechnology firm dedicated to improving access to mental health treatments, focuses on the develop…

Cashu Finance·over 1 year ago

Compass Pathways Appoints Dr. Steve Levine to Enhance Patient-Centric Mental Health Care

Compass Pathways Strengthens Commitment to Patient-Centric Care with New Appointment Compass Pathways plc, a leading biotechnology company devoted to improving mental health care access, announces the…

Cashu Finance·almost 2 years ago

Compass Pathways Plc Secures $150 Million Funding for Mental Health Innovations

Compass Pathways Secures Funding to Propel Mental Health Innovations Compass Pathways plc, a biotechnology company dedicated to advancing mental health treatments, announces a significant underwritten…

Cashu Finance·almost 2 years ago

Compass Pathways Plc Joins NASDAQ Biotechnology Index, Enhancing Mental Health Innovation

Compass Pathways Joins NASDAQ Biotechnology Index, Advancing Mental Health Solutions Compass Pathways Plc (Nasdaq: CMPS), a pioneering biotechnology firm dedicated to improving mental health treatment…

Cashu Finance·almost 2 years ago

Compass Pathways Plc: Leading the Charge in Psilocybin Therapy for Mental Health Treatment

Compass Pathways: Pioneering Mental Health Innovations in a Transformative Landscape Compass Pathways Plc is at the forefront of revolutionizing mental health treatment with its innovative approach to…

Cashu Finance·almost 2 years ago

Compass Pathways Plc: Leading Innovation in Psilocybin Treatment for Mental Health Challenges

### Navigating the Future of Mental Health Treatment: Compass Pathways' Innovative Approach Compass Pathways Plc is at the forefront of revolutionizing mental health treatment through its pioneering u…

Cashu Finance·almost 2 years ago

Compass Pathways Plc: Navigating Opportunities and Challenges in the Evolving Cannabis Landscape

Navigating the Evolving Cannabis Landscape: Opportunities and Challenges for Compass Pathways Plc The cannabis industry is undergoing significant transformation, presenting both challenges and opportu…

Cashu Finance·almost 2 years ago

Compass Pathways Plc: Leading Innovation in the Evolving Cannabis Industry for Mental Health

Navigating the Evolution of the Cannabis Industry: Compass Pathways Plc's Strategic Position The cannabis industry is currently experiencing a transformative phase, necessitating a proactive approach…

Cashu Finance·almost 2 years ago

Compass Pathways Plc: Innovating in the Transformative Cannabis Industry for Future Growth

Title: Navigating the Evolving Landscape of the Cannabis Industry: A Focus on Innovation and Consumer Engagement The cannabis industry is currently experiencing a transformative phase that presents bo…

Cashu Finance·almost 2 years ago

Clarification Needed: No Content Provided on Compass Pathways Plc Developments

It appears there has been a misunderstanding, as I don’t have any content provided to summarize. If you can share the specific text or details regarding Compass Pathways Plc or relevant developments i…

Cashu Finance·almost 2 years ago

Compass Pathways Plc Prioritizes COMP360 Amid Financial Losses and Strategic Restructuring

### Strategic Refocus on COMP360 Amid Financial Challenges Compass Pathways Plc, a pioneering biotechnology firm dedicated to mental health innovation, is actively refocusing its efforts on its flagsh…

Cashu Finance·almost 2 years ago